Nabil F. Saba
Contributor at Freelance
Director of Head & Neck Oncology, Vice Chair at @WinshipAtEmory. Medical Oncologist; H&N cancer expert. Opinions=my own https://t.co/CXZsMJ6Sg2
Articles
-
2 months ago |
nature.com | Matthew Morrow |David Lott |Seth Pransky |Nabil F. Saba |Sarah Marcus |Emma L. Reuschel
AbstractRecurrent respiratory papillomatosis (RRP) is a chronic airway disease caused by Human Papillomavirus (HPV). INO-3107, DNA immunotherapy designed to elicit T-cells against HPV-6 and HPV-11, was evaluated in a 52-week Phase 1/2 study for efficacy, safety, and immunogenicity (NCT04398433).
-
May 29, 2024 |
thelancet.com | Nabil F. Saba
Nasopharyngeal carcinoma is a subset of head and neck cancers characterised by association with the Epstein–Barr virus and a distinct tumour immune microenvironment.
-
Jun 20, 2023 |
fal.cn | Nabil F. Saba
-
Jun 20, 2023 |
fal.cn | Nabil F. Saba
Nabil F.
-
Jun 20, 2023 |
onclive.com | Nabil F. Saba
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 1K
- Tweets
- 466
- DMs Open
- No
RT @eaonc: EA3231 is a phase 3 #ClinicalTrial of targeted therapy vs. chemotherapy in patients with differentiated #ThyroidCancer (DTC) wit…
RT @anantm: 🚨 New pub alert in Eur J of Cancer🚨 We introduce VISTA, an AI-virtual staining tool transforming H&E to IHC to detect M2-TAMs i…
RT @anantm: In @eBioMedicine we present SMuRF, a Swin Transformer-based model for fusing CT & HE slides to predict survival & tumor grade i…
